You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
【音頻】格隆匯4.27盤前要點—港A美股你需要關注的大事都在這

格隆匯4月27日丨1、美股三大指數大幅收跌 科技股跳水納指下挫近4%;

2、美油重返100美元 比特幣失守3.8萬美元;

3、谷歌(GOOGL.US)盤後一度跌約7% 一季度盈利超預期下降 創兩年最低季營收增速;

4、微軟(MSFT.US)盤後漲近6% 一季度營收利潤均高於預期;

5、孫春蘭在滬調研指導疫情防控工作:聚焦重點區域集中發力 以總攻姿態拔點攻堅;

6、傳聞的“國家隊”大幅減持數據錯的離譜!真實情況:持倉穩定;

7、上海市證券、期貨、基金同業公會齊發聲:堅定維護市場穩定 發揮行業機構積極作用;

8、中央財經委:全面加強基礎設施建設構建現代化基礎設施體系;

9、中央財經委員會:要引導好市場預期 講清楚政策導向和原則 穩定市場信心;

10、中央財經委員會:要加強交通、能源、水利等網絡型基礎設施建設;

11、證監會發文推進公募基金行業高質量發展 強調提高中長期資金佔比;

12、證監會:加快推進公募基金行業高質量發展 積極培育專業資產管理機構;

13、證監會:採取有效監管措施限制“風格漂移”、“高換手率”等博取短線交易收益的行為;

14、證監會:引導公募基金管理人扭轉過度依賴“明星基金經理”的發展模式;

15、多家大行下調普通定期存款利率;

16、財政部:一季度國有企業利潤總額10187.4億元,同比增7%;

17、北上資金逆勢淨買入白酒股;南下資金連續16日淨買入美團 累計超87億港元;

18、波羅的海乾散貨運價指數升至四周高點;

19、白皮書:儲能產業鏈投資計劃已經超過了1.2萬億元;

20、世界銀行:預計2022年能源價格比去年上漲50.5%;

21、國家藥監局:深化中藥審評審批和監管體制機制改革;

22、中國生物奧密克戎變異株新冠滅活疫苗獲國家藥監局臨牀批件;SINOVAC科興奧密克戎株新冠疫苗在國內獲批臨牀;

23、貴州茅台:一季度淨利潤172.45億元 同比增長23.58%;

24、中芯國際:六成以上上海員工已在閉環內 產能利用率保持在較高水平;

25、温氏股份:一季度淨虧損37.63億元;

26、復星醫藥:一季度淨利4.63億元,同比下降45.41%;

27、東原仁知服務(2352.HK)將於本週五上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account